Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema

被引:353
作者
Ding, Jie [1 ,2 ,3 ]
Wong, Tien Yin [1 ,3 ]
机构
[1] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore
[2] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore
关键词
Epidemiology; Diabetic retinopathy; Diabetic macular edema; Risk factors; URBAN-RURAL EPIDEMIOLOGY; RANIBIZUMAB PLUS PROMPT; RISK-FACTORS; FOLLOW-UP; FOCAL/GRID PHOTOCOAGULATION; INTRAVITREAL TRIAMCINOLONE; MEXICAN-AMERICANS; DEFERRED LASER; BLOOD-PRESSURE; SERUM-LIPIDS;
D O I
10.1007/s11892-012-0283-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With increasing global prevalence of diabetes, diabetic retinopathy (DR) is set to be the principle cause of vision impairment in many countries. DR affects a third of people with diabetes and the prevalence increases with duration of diabetes, hyperglycemia, and hypertension-the major risk factors for the onset and progression of DR. There are now increasing data on the epidemiology of diabetic macular edema (DME), an advanced complication of DR, with studies suggesting DME may affect up to 7 % of people with diabetes. The risk factors for DME are largely similar to DR, but dyslipidemia appears to play a more significant role. Early detection of DR and DME through screening programs and appropriate referral for therapy is important to preserve vision in individuals with diabetes. Future research is necessary to better understand the potential role of other risk factors such as apolipoproteins and genetic predisposition to shape public health programs.
引用
收藏
页码:346 / 354
页数:9
相关论文
共 89 条
[1]   A Systematic Meta-Analysis of Genetic Association Studies for Diabetic Retinopathy [J].
Abhary, Sotoodeh ;
Hewitt, Alex W. ;
Burdon, Kathryn P. ;
Craig, Jamie E. .
DIABETES, 2009, 58 (09) :2137-2147
[2]  
[Anonymous], NEW ENGL J MED
[3]  
[Anonymous], INVEST OPHTHALM 0316
[4]   Heritability of the severity of diabetic retinopathy: The FIND-Eye study [J].
Arar, Nedal H. ;
Freedman, Barry I. ;
Adler, Sharon G. ;
Iyengar, Sudha K. ;
Chew, Emily Y. ;
Davis, Mathew D. ;
Satko, Scott G. ;
Bowden, Donald W. ;
Duggirala, Ravi ;
Elston, Robert C. ;
Guo, Xiuxing ;
Hanson, Robert L. ;
Igo, Robert P., Jr. ;
Ipp, Eli ;
Kimmel, Paul L. ;
Knowler, William C. ;
Molineros, Julio ;
Nelson, Robert G. ;
Pahl, Madeleine V. ;
Quade, Shannon R. E. ;
Rasooly, Rebekah S. ;
Rotter, Jerome I. ;
Saad, Mohammed F. ;
Scavini, Marina ;
Schelling, Jeffrey R. ;
Sedor, John R. ;
Shah, Vallabh O. ;
Zager, Philip G. ;
Abboud, Hanna E. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (09) :3839-3845
[5]  
Beck RW, 2009, ARCH OPHTHALMOL-CHIC, V127, P245, DOI 10.1001/archophthalmol.2008.610
[6]   Differential Association of Serum Lipids with Diabetic Retinopathy and Diabetic Macular Edema [J].
Benarous, Rehab ;
Sasongko, Muhammad B. ;
Qureshi, Salmaan ;
Fenwick, Eva ;
Dirani, Mohamed ;
Wong, Tien Y. ;
Lamoureux, Ecosse L. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (10) :7464-7469
[7]   Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes - The EURODIAB Prospective Complications Study [J].
Chaturvedi, N ;
Sjoelie, AK ;
Porta, M ;
Aldington, SJ ;
Fuller, JH ;
Songini, M ;
Kohner, EM .
DIABETES CARE, 2001, 24 (02) :284-289
[8]   Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials [J].
Chaturvedi, Nish ;
Porta, Massimo ;
Klein, Ronald ;
Orchard, Trevor ;
Fuller, John ;
Parving, Hans Henrik ;
Bilous, Rudy ;
Sjolie, Anne Katrin .
LANCET, 2008, 372 (9647) :1394-1402
[9]   The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives [J].
Chen, Lei ;
Magliano, Dianna J. ;
Zimmet, Paul Z. .
NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (04) :228-236
[10]  
Cheung N, 2008, LANCET, V371, P721, DOI 10.1016/S0140-6736(08)60333-5